PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24398310-14	2014	In VATS and TOS groups, the serum VEGF and MMP-9 levels also initially increased and subsequently decreased.	tos	12-15	matrix metallopeptidase 9	Homo sapiens	43-48	
24398310-17	2014	CONCLUSIONS: Serum VEGF and MMP-9 remarkably increase in TOS group and VATS group.	tos	57-60	matrix metallopeptidase 9	Homo sapiens	28-33	
24398310-18	2014	Although the serum level of VEGF an MMP-9 in TOS group were higher than that in VATS group.	tos	45-48	matrix metallopeptidase 9	Homo sapiens	36-41	
31349003-14	2019	The levels of MMP-2 and MMP-9/tissue inhibitors of metalloproteinases (TIMP)-1 ratio (MMP-9/ TIMP-1), also decreased significantly and the decline could be associated with TOS.	tos	172-175	matrix metallopeptidase 9	Homo sapiens	24-29	
31349003-14	2019	The levels of MMP-2 and MMP-9/tissue inhibitors of metalloproteinases (TIMP)-1 ratio (MMP-9/ TIMP-1), also decreased significantly and the decline could be associated with TOS.	tos	172-175	matrix metallopeptidase 9	Homo sapiens	86-91